Armstrong Advisory Group
RMD icon

Armstrong Advisory Group’s ResMed RMD Stock Holding History

Armstrong Advisory Group’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.88K Buy
13
+4
+44% +$873 ﹤0.01% 876
2026
Q2 		$1.75K Sell
9
-18
-67% -$3.73K ﹤0.01% 917
2026
Q1 		$6.06K Hold
27
– – ﹤0.01% 768
2025
Q4 		$6.5K Sell
27
-19
-41% -$4.86K ﹤0.01% 746
2025
Q3 		$12.6K Buy
46
+1
+2% +$273 ﹤0.01% 639
2025
Q2 		$11.6K Buy
+45
New +$10.7K ﹤0.01% 639

Other funds holding RMD

Vest Financial
Vest Financial Mclean, Virginia $9.5B AUM 22.78% 1-Year Est. Return
Washington Trust Advisors
Washington Trust Advisors Wellesley, Massachusetts $1.4B AUM 26.88% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Confluence Investment Management
Confluence Investment Management St. Louis, Missouri $5.97B AUM 5.11% 1-Year Est. Return
MassMutual Private Wealth & Trust
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
Fideuram - Intesa Sanpaolo Private Banking
Fideuram - Intesa Sanpaolo Private Banking Turin $3.5B AUM 45.13% 1-Year Est. Return
NorthCrest Asset Manangement
NorthCrest Asset Manangement Plymouth, Minnesota $4.24B AUM 32.82% 1-Year Est. Return
Addenda Capital
Addenda Capital Montreal, Quebec, Canada $3.78B AUM 23.53% 1-Year Est. Return

Armstrong Advisory Group's RMD Position: Q3 2026 in Review

Armstrong Advisory Group increased its ResMed (RMD) stake by 44% in Q3 2026, buying an estimated $873 and bringing the position to 13 shares worth $2.88K. The position accounts for ﹤0.01% of the portfolio, ranked #876.

Armstrong Advisory Group first reported a position in RMD in Q2 2025 and has held it in 6 quarters since. The position peaked at $12.6K in Q3 2025. 166 funds tracked by Wall St. Rank hold RMD as of Q3 2026.

  • Armstrong Advisory Group held 13 shares of ResMed worth $2.88K as of Q3 2026.
  • Armstrong Advisory Group bought 4 ResMed shares in Q3 2026, an estimated $873.
  • ResMed made up ﹤0.01% of Armstrong Advisory Group's portfolio in Q3 2026, its #876 holding.
  • Armstrong Advisory Group first reported a position in ResMed in Q2 2025 and has held it in 6 quarters since.
  • Armstrong Advisory Group's ResMed position peaked at $12.6K in Q3 2025.
  • 166 funds tracked by Wall St. Rank held ResMed as of Q3 2026.

Based on Armstrong Advisory Group's 13F filing for Q3 2026, filed 9 Oct 2026.